Hrt Financial LP Avid Bioservices, Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 177,634 shares of CDMO stock, worth $2.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

177,634

Previous 126,701 40.2%

Holding current value

$2.18 Million

Previous $904,000 123.56%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$6.7 - $12.45 $341,251 - $634,115	50,933 Added 40.2%	177,634 $2.02 Million
Q2 2024 Aug 12, 2024	BUY	$6.34 - $9.28 $803,284 - $1.18 Million	126,701 New	126,701 $904,000
Q4 2023 Feb 09, 2024	BUY	$4.64 - $9.56 $1.88 Million - $3.86 Million	404,260 Added 1059.3%	442,423 $2.88 Million
Q3 2023 Nov 13, 2023	BUY	$9.4 - $14.04 $358,732 - $535,808	38,163 New	38,163 $360,000
Q1 2023 May 12, 2023	BUY	$13.48 - $18.79 $1.08 Million - $1.5 Million	79,942 New	79,942 $1.5 Million
Q2 2022 Aug 12, 2022	BUY	$11.63 - $21.55 $455,186 - $843,445	39,139 Added 296.89%	52,322 $798,000
Q1 2022 May 16, 2022	SELL	$16.63 - $27.73 $145,229 - $242,166	-8,733 Reduced 39.85%	13,183 $268,000
Q4 2021 Feb 14, 2022	BUY	$20.7 - $34.18 $453,661 - $749,088	21,916 New	21,916 $639,000
Q1 2021 May 17, 2021	SELL	$11.86 - $21.77 $398,590 - $731,646	-33,608 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.25 - $11.76 $243,658 - $395,230	33,608 New	33,608 $387,000
Q4 2019 Feb 14, 2020	SELL	$5.01 - $8.16 $64,518 - $105,084	-12,878 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.07 - $7.08 $65,291 - $91,176	12,878 New	12,878 $68,000

Others Institutions Holding CDMO

# of Institutions

183

Shares Held

67.8M

Call Options Held

89.9K

Put Options Held

118K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $762M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account